Skip to main content

Table 1 Clinicopathological characteristics of the NSCLC cohort

From: Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients

  AC SCC
N (%) N (%)
Tumour stage (pT)    
  1 29 (21.2 %) 5 (3.6)
  2 51 (37.2 %) 23 (16.8 %)
  3 6 (4.4 %) 6 (4.4 %)
  4 1 (0.7 %) 0 (0 %)
Nodal Status (pN) 0 37 (27.0 %) 15 (10.9 %)
  1 15 (10.9 %) 9 (6.6 %)
  2 14 (10.2 %) 3 (2.2 %)
  3 1 (0.7 %) 0 (0.0 %)
Grading (G) 1 5 (3.6 %) 0 (0.0 %)
  2 41 (29.9 %) 16 (11.6 %)
  3 44 (32.1 %) 17 (12.4 %)
Mean age at surgery   64,2 64,56
(median age)   (65) (67)
Sex (m:w)   68:34 30:5
Median OS (months)   52 24
(SD; 95 % CI [months])   (±23.7; 5.5– 98.5) (± 12.8;0.0– 49.0)
  1. SD standard deviation; CI confidence interval; n number of cases; OS overall survival